Most people pay far too much for a GLP-1 because they never line up the four savings tools that exist: manufacturer copay cards, manufacturer self-pay programs, third-party discount cards, and patient assistance programs. Each one fits a different situation, and the rules about combining them trip up almost everyone. This guide lays out every program in 2026, what you actually qualify for, and the stacking rules that decide your real out-of-pocket cost.
For the bigger picture, see the GLP-1 price comparison, the cheapest GLP-1 paths ranked, and the insurance coverage guide.
Direct answer: If you have commercial insurance that covers the drug, the manufacturer copay card — the same thing the drugmakers call a savings card and most people search for as a GLP-1 coupon — is the winner: as little as $25/month, capped at $100–$150 of savings per 1-month fill. If you have no coverage, skip the card (it requires commercial insurance) and use manufacturer self-pay: NovoCare sells the Wegovy and Ozempic pen at $199/month for the first two fills, then $349; the Wegovy pill starts at $149; LillyDirect sells Zepbound at $299–$699 depending on dose. On Medicare, the GLP-1 Bridge has capped both Wegovy and Zepbound at about $50/month since July 1, 2026. GoodRx is the fallback at any pharmacy but cannot be combined with a copay card. Patient assistance programs give the drug free to low-income, uninsured patients. Government beneficiaries (Medicare/Medicaid) are excluded from both copay cards and self-pay programs.
The four savings tools at a glance
| Tool | Who it is for | Typical cost | Key limit |
|---|---|---|---|
| Manufacturer copay card (a.k.a. savings card, GLP-1 coupon) | Commercially insured, drug covered | $25/mo | Excludes Medicare/Medicaid; $100–$150 savings cap per fill |
| Manufacturer self-pay program | Uninsured or drug not covered | $149–$449/mo | Cash only; no government plans |
| Third-party discount card (GoodRx, SingleCare) | Anyone, especially uninsured | $199–$349/mo | Cannot stack with a copay card |
| Patient assistance program (PAP) | Uninsured, low income | $0 | Strict income documentation |
Manufacturer copay cards (the best deal with insurance)
We maintain dedicated, brand-by-brand breakdowns of every card's current terms. For the full route-by-route guides see Zepbound coupon, Wegovy coupon, Mounjaro coupon, and Ozempic coupon. For the official manufacturer card terms, eligibility, and enrollment, see the savings-card deep dives: Zepbound, Wegovy, Mounjaro, and Ozempic.
A copay card lowers what you pay at the counter when your commercial plan already covers the drug. It does nothing on its own — it sits on top of insurance.
- Wegovy Savings Offer (Novo Nordisk): as little as $25/month for commercially insured patients whose plan covers Wegovy, subject to a maximum savings of $100/month. A month is defined as one box of four pens, or one bottle of 30 tablets for the pill. If your plan does not cover Wegovy, the self-pay price below beats the card.
- Ozempic Savings Offer (Novo Nordisk): as little as $25 per month for up to 3 months for covered patients, subject to a maximum savings of $100/month.
- Zepbound Savings Card (Eli Lilly): as little as $25 for a 1-month, 2-month, or 3-month fill for covered commercial patients, capped at $100/$200/$300 of savings respectively and $1,300 per calendar year. If your plan does not cover Zepbound, the card drops the single-dose pen to $499/month for up to 13 fills a year, or $299/month on the KwikPen or vial.
- Mounjaro Savings Card (Eli Lilly): as little as $25 for a 1-month, 2-month, or 3-month fill for commercially insured type 2 diabetes patients, capped at $150/$300/$450 of savings respectively and $1,950 per calendar year. Without coverage, the card brings it to as low as $499/month, capped at $647/month and $8,411 per calendar year.
The universal catch: copay cards exclude anyone with Medicare, Medicaid, or other government insurance. Lilly spells the list out — Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE/CHAMPUS, or any state prescription drug assistance program — and Novo Nordisk states it as "government beneficiaries excluded." That exclusion is federal law, not a manufacturer choice. Both companies also require you to be 18 or older and to activate the card before the pharmacy can apply it. If you are on Medicare, go straight to the GLP-1 Bridge, which has been live since July 1, 2026.
Every GLP-1 manufacturer coupon compared
A GLP-1 manufacturer coupon, a savings card and a copay card are all the same instrument: the discount the drugmaker itself funds at the pharmacy counter. Novo Nordisk brands it a Savings Offer, Eli Lilly brands it a Savings Card, and patients, prescribers and pharmacists all call it a coupon. There is no fifth, better GLP-1 coupon behind a different name — if a site is selling you one, it did not come from the manufacturer.
Here is what each of the four coupons is worth in 2026, taken from the manufacturers' own terms:
| Coupon | You pay if your plan covers it | Max savings per fill | Annual cap | If your plan does not cover it |
|---|---|---|---|---|
| Wegovy Savings Offer (Novo Nordisk) | As little as $25/month | $100/month | Not stated on the offer page | Self-pay: $199/mo for two fills, then $349 ($399 for HD 7.2 mg) |
| Ozempic Savings Offer (Novo Nordisk) | As little as $25/month for up to 3 months | $100/month | Offer runs up to 3 months | Self-pay: $199/mo for two fills, then $349 (0.25–1 mg) or $499 (2 mg) |
| Zepbound Savings Card (Eli Lilly) | As little as $25 per 1-, 2- or 3-month fill | $100 / $200 / $300 by fill length | $1,300 per calendar year | $499/mo single-dose pen, up to 13 fills a year; $299/mo KwikPen or vial |
| Mounjaro Savings Card (Eli Lilly) | As little as $25 per 1-, 2- or 3-month fill | $150 / $300 / $450 by fill length | $1,950 per calendar year | As low as $499/mo, capped at $647/mo and $8,411 a year |
Two columns in that table decide your real cost. The maximum savings is the ceiling on what the manufacturer contributes to a single fill, so if your plan leaves $400 on the counter and the cap is $100, you pay $300 — not $25. The annual cap is what ends the discount partway through the year: on Zepbound, $1,300 of savings is roughly eight or nine 1-month fills at the cap before the coupon stops paying anything.
The Lilly cards also reward a longer script. Because the caps scale with fill length, asking your prescriber for a 3-month prescription gets you $25 total for three months rather than $25 three times, and it uses less of the annual cap per month of medication.
How to get a manufacturer coupon for a GLP-1, step by step:
- Get the prescription first. Every one of these programs requires an active prescription for an FDA-approved use before enrollment means anything.
- Enroll with the drugmaker, not the pharmacy. For Wegovy, text SAVE to 83757 or answer the eligibility questions on NovoCare. For Ozempic, text BEGIN to 21848 or use the same online form. For Zepbound and Mounjaro, enroll through the savings card portal on Lilly's product site.
- Activate the card. Lilly states plainly that card activation is required; an un-activated card will not process. You must be 18 or older and live in the US or Puerto Rico.
- Hand the card details to the pharmacy with the script. The pharmacy runs it as a secondary claim after your insurance, which is why it only works when you have commercial coverage.
- Re-check the price at every dose escalation. Moving from 5 mg to 7.5 mg can change both the plan's negotiated price and which side of the cap you land on.
One thing nobody mentions: these coupons run outside your insurance. Novo Nordisk states it directly — the money spent and the discount on your prescription will not count toward your deductible or out-of-pocket maximum. If you are close to meeting a deductible, the card can quietly work against you.
Manufacturer self-pay programs (best without insurance)
When insurance does not cover the drug — or you have none — the manufacturers sell directly at far below retail:
- NovoCare Pharmacy (Wegovy, Ozempic): the Wegovy pen is $199/month for the first two monthly fills of 0.25 mg or 0.5 mg, an intro offer running through December 31, 2026, then $349/month for 0.25 mg through 2.4 mg and $399/month for Wegovy HD 7.2 mg. The Wegovy pill is $149/month for 1.5 mg and 4 mg, though the 4 mg price is only held until August 31, 2026 and then moves to $199/month. The Ozempic pen follows the same $199 intro for two fills, then $349/month for 0.25 mg, 0.5 mg or 1 mg and $499/month for 2 mg. Prescription required; home delivery or pharmacy pickup.
- LillyDirect Self Pay (Zepbound): the single-patient-use KwikPen and the vials list at $299 (2.5 mg), $399 (5 mg), $499 (7.5 mg) and $699 (10 mg, 12.5 mg and 15 mg). A purchase offer applies automatically on your first fill at 7.5 mg and above and brings those doses to $449/month, so the price you see quoted is usually the offer price rather than the list price. Available by direct ship or pharmacy pickup.
These are cash programs and, like copay cards, exclude government beneficiaries. They are detailed channel-by-channel in the pharmacy pricing map. Cost is only half the decision, and patient-reported GLP-1 reviews are worth reading before you commit to a specific drug.
Third-party discount cards
GoodRx, SingleCare, and similar cards negotiate cash prices at retail pharmacies. GoodRx now runs GLP-1-specific pricing: $199/month introductory for the first two Ozempic or Wegovy fills, then $299–$349, with an optional $39/month telehealth visit. The Wegovy pill runs under $150. Discount cards are the most flexible option — they work for almost anyone at almost any pharmacy — but they cannot be combined with a manufacturer copay card. You choose one.
Patient assistance programs (free drug)
Both manufacturers run patient assistance programs (PAPs) that provide the medication at no cost to patients who are uninsured and below an income threshold (commonly around 400% of the federal poverty level). These require an application, proof of income, and usually a prescriber''s sign-off, and they are not advertised prominently — but for qualifying patients they are the cheapest option that exists. Start at the manufacturer''s patient-assistance page (NovoCare and Lilly Cares).
The Medicare GLP-1 Bridge: about $50 a month, and it is already live
Copay cards are closed to Medicare and Medicaid, but since July 1, 2026 there is a federal program that is not. The Medicare GLP-1 Bridge is a temporary demonstration that gives eligible Medicare Part D beneficiaries a fixed price on branded GLP-1s through December 31, 2027. It is nationwide, in every state and territory.
| Drug | Price under the Bridge | Scope |
|---|---|---|
| Wegovy pen and Wegovy pill | $50/month | All dose strengths |
| Zepbound | No more than $50/month | Terms apply |
Two things have to be true to get it: you are enrolled in an eligible Part D plan, and your prescriber submits a prior authorization for a medical use covered under the Bridge. Eligibility criteria are set by the Centers for Medicare & Medicaid Services, not by the manufacturer, so a plan cannot decline you for a reason of its own invention. For a Medicare beneficiary this is the cheapest legitimate route in 2026 — it beats every cash program on this page, and it replaces the "there is nothing for you on Medicare" answer that was true before July.
The stacking rules everyone gets wrong
- Copay card + insurance: yes — this is the intended combination and the cheapest legitimate path.
- Copay card + GoodRx/discount card: no — you cannot use both on the same fill. Pick whichever is lower (the copay card wins when insurance covers the drug).
- Copay card + Medicare/Medicaid: prohibited by law.
- Self-pay program + insurance: no — self-pay means you are not running it through insurance at all.
- GoodRx + Medicare: allowed, because GoodRx is a cash discount, not insurance — but you cannot apply it to a drug you are also billing to Medicare.
How to choose in 60 seconds
- Commercial insurance that covers the drug? Use the manufacturer copay card. Done — as little as $25/month, as long as your plan's share stays under the card's per-fill cap.
- Commercial insurance that excludes the drug, or no insurance? Compare manufacturer self-pay (NovoCare/LillyDirect) against GoodRx for your exact drug and dose.
- Uninsured and low income? Apply to the patient assistance program for $0 drug.
- On Medicare or Medicaid? Copay cards and self-pay are off-limits. Check the Medicare GLP-1 Bridge first: $50/month for the Wegovy pen and pill and no more than $50/month for Zepbound, live since July 1, 2026 and running through December 31, 2027.
What people get wrong
- "The savings card works no matter what." It requires commercial insurance and excludes government plans. Uninsured patients need self-pay or a PAP instead.
- "I can stack GoodRx on top of my copay card." You cannot. One discount per fill.
- "Self-pay is the same as using my insurance." No — self-pay programs bypass insurance entirely, which is why they exclude Medicare/Medicaid.
- "There''s no help if my plan excludes the drug." There is: manufacturer non-covered offers, self-pay programs, GoodRx, and PAPs all exist for exactly this case.
- "$25 a month means I pay $25, whatever the drug costs." No. The coupon pays up to a cap — $100/month on the Novo offers, $100 per 1-month fill on Zepbound, $150 on Mounjaro. Anything your plan leaves above that cap is yours.
- "The coupon counts toward my deductible." It does not. Manufacturer offers operate outside third-party insurance, and Novo Nordisk states that the discount will not count toward your deductible or out-of-pocket requirements.
Frequently asked questions
What is the cheapest way to pay for a GLP-1? Commercial insurance plus a manufacturer copay card: as little as $25/month, provided your plan's share stays under the card's cap. On Medicare, the GLP-1 Bridge is cheaper still at about $50/month. Without insurance, manufacturer self-pay runs from $149/month for the Wegovy pill and $199/month introductory (then $349) for the pens, or $0 through a patient assistance program if you qualify. The cheapest GLP-1 paths ranked compares them side by side.
Can I use a manufacturer savings card with Medicare? No. Federal anti-kickback rules exclude Medicare, Medicaid, and other government beneficiaries from manufacturer copay cards. That is not the end of the road, though: the Medicare GLP-1 Bridge prices the Wegovy pen and pill at $50/month and Zepbound at no more than $50/month for eligible Part D beneficiaries through December 31, 2027.
Can I combine GoodRx with a copay card? No. You can use only one discount per prescription fill. Compare them and choose the lower price — usually the copay card when insurance covers the drug.
My insurance does not cover Wegovy. What now? Use NovoCare self-pay (from $149 for the pill, $349 for injection), compare against GoodRx, and check whether you qualify for a patient assistance program. See the cheapest GLP-1 guide.
Do these programs work for compounded GLP-1? No. Manufacturer cards and self-pay programs apply only to branded, FDA-approved products. Compounded drugs are priced separately by the compounding pharmacy or telehealth provider.
How do I get a manufacturer coupon for a GLP-1? You enroll with the drugmaker, not at the pharmacy, and you need the prescription first. For Wegovy, text SAVE to 83757 or complete the eligibility questions on NovoCare. For Ozempic, text BEGIN to 21848 or use the online form. For Zepbound and Mounjaro, enroll through the savings card portal on Lilly's product site and activate the card, which Lilly requires before a pharmacy can process it. All four need commercial insurance, an FDA-approved indication, and that you be 18 or older in the US or Puerto Rico. Enrollment is free and takes a few minutes.
Is a GLP-1 coupon the same thing as a savings card or a copay card? Yes. Novo Nordisk calls it a Savings Offer, Eli Lilly calls it a Savings Card, and patients and pharmacists call it a copay card or a coupon. They all describe the same manufacturer-funded discount. There is no separate, better GLP-1 coupon circulating elsewhere.
Do GLP-1 coupons count toward my deductible? No. These offers operate outside of any third-party insurance, and Novo Nordisk states that the money spent and the discounts on your prescription will not count toward your deductible or out-of-pocket requirements. If you are close to meeting a deductible, run the math both ways before using the card.
Which GLP-1 is cheapest right now? On cash price, the Wegovy pill at $149/month is the cheapest branded GLP-1, followed by the $199/month introductory pen pricing from NovoCare and Zepbound's $299/month 2.5 mg KwikPen or vial. With commercial coverage, all four brands land at about $25/month with a coupon. See the cheapest GLP-1 paths ranked for the full ordering.
Last reviewed: August 20, 2026
Sources
- GLP-1 Drug Savings: How to Save on Ozempic, Wegovy, and More — GoodRx
- Discounts on GLP-1 Medications — GoodRx
- Save on Wegovy — Novo Nordisk
- NovoCare Pharmacy — Novo Nordisk
- Zepbound Savings and Support — Eli Lilly
- Authentic Zepbound Shipped to You — LillyDirect
- Ozempic Savings Offer — NovoCare
- Ozempic Self-Pay Pricing at NovoCare Pharmacy — NovoCare
- Mounjaro Savings and Resources — Eli Lilly
References
- U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. (Manufacturer savings programs apply only to FDA-approved branded products, not compounded drugs.)
- U.S. Food and Drug Administration. WEGOVY (semaglutide) injection — Prescribing Information. (Approved branded GLP-1 product referenced in the savings programs above.)







